| Price Range 12mo avg: | $940K – $6.3M |
|---|---|
| $/sf 12mo avg: | $376 |
| CAP Rate 12mo avg: | 6.87% |
| NOI average: | $193,167 |
| Lease Terms: | 15yrs NN |
| Building Size avg: | 8,000 SF |
| Lot Size avg: | 0.75+/- acres |
DaVita Kidney Care is a division of DaVita HealthCare Partners Inc., a Fortune 500® company that, through its operating divisions, provides a variety of health care services to patient populations throughout the United States and abroad. A leading provider of dialysis services in the United States, DaVita Kidney Care treats patients with chronic kidney failure and end stage renal disease. DaVita Kidney Care strives to improve patients’ quality of life by innovating clinical care, and by offering integrated treatment plans, personalized care teams and convenient health management services. As of September 30, 2015, DaVita Kidney Care operated or provided administrative services at 2,225 outpatient dialysis centers located in the United States serving approximately 177,000 patients. The company also operated 104 outpatient dialysis centers located in 10 countries outside the United States. DaVita Kidney Care supports numerous programs dedicated to creating positive, sustainable change in communities around the world. The company’s leadership development initiatives and social responsibility efforts have been recognized by Fortune, Modern Healthcare, Newsweek and WorldBlu.
DaVita—which is Italian for “giving life”—has more than 50,000 teammates (employees) around the nation working to provide superior patient care and exemplify the company’s Core Values
| S&P Credit Rating: | BB- |
|---|---|
| Moody’s Credit Rating: | Ba3 |
| Annual Revenue 2014: | $12.8B |
| Annual Revenue 2013: | $11.8B |
| Revenue Growth: | ↑ 8.13% from 2013 |
| Net Income | $723M |
| Units (Dec. 2014) | 2,179 |
| Average Units Volume: | $331856K |
Yahoo! Finance: DVA News Latest Financial News for DVA
-
Why DaVita HealthCare (DVA) Might be Well Poised for a Surge
on November 14, 2019 at 3:20 pm
DaVita HealthCare (DVA) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions. […]
-
DVA or CHE: Which Is the Better Value Stock Right Now?
on November 12, 2019 at 2:30 pm
DVA vs. CHE: Which Stock Is the Better Value Option? […]
-
Is DaVita (DVA) Stock Outpacing Its Medical Peers This Year?
on November 12, 2019 at 2:30 pm
Is (DVA) Outperforming Other Medical Stocks This Year? […]
-
Are Investors Undervaluing DaVita HealthCare (DVA) Right Now?
on November 12, 2019 at 2:10 pm
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks. […]
-
Can You Imagine How DaVita's (NYSE:DVA) Shareholders Feel About The 15% Share Price Increase?
on November 12, 2019 at 1:13 pm
Low-cost index funds make it easy to achieve average market returns. But across the board there are plenty of stocks... […]
NYSE: DVA
